检索结果 - Andrea B. Apolo
- Showing 1 - 20 results of 51
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy 由 Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi, Alexia Iasonos, George Philips, Jonathan E. Rosenberg, Jamie C. Riches, Eric J. Small, Matthew I. Milowsky, Dean F. Bajorin
出版 2013Artigo -
14
-
15
-
16
-
17
Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer 由 Arjun Vasant Balar, Andrea B. Apolo, Irina Ostrovnaya, Svetlana Mironov, Alexia Iasonos, A. Trout, Ashley Marie Regazzi, Ilana Garcia-Grossman, David Gallagher, Matthew I. Milowsky, Dean F. Bajorin
出版 2013Artigo -
18
-
19
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, rando... 由 David Cella, Robert J. Motzer, Cristina Suárez, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel Wallace, Burçin Şimşek, Joshua Zhang, Cristina Ivanescu, Andrea B. Apolo, Toni K. Choueiri
出版 2022Artigo -
20
相关主题
Medicine
Internal medicine
Cancer
Oncology
Bladder cancer
Immunotherapy
Urology
Biology
Chemotherapy
Clinical trial
Nivolumab
Cabozantinib
Renal cell carcinoma
Genetics
Adverse effect
Cancer research
Prostate cancer
Urothelial carcinoma
Confidence interval
Gene
Metastatic Urothelial Carcinoma
Biochemistry
Cisplatin
Clinical endpoint
Disease
Gastroenterology
Hazard ratio
Sunitinib
Bioinformatics
Immunology